Psyence Biomedical Statistics

NASDAQ: PBMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.97-0.15 (-2.93%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Psyence Biomedical by the numbers

With trailing EPS of $-12.56, Psyence Biomedical is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.8% above its 50-day average and 22.7% below its 200-day average. Average daily trading volume is 94.85K shares, or about $471,395 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PBM valuation vs. peer median

PBM compared with the median of 8 peer companies
Metric	PBM	Peer median	Difference
Avg. volume	94.85K	111.37K	-15%

Peer median across 8 companies: AKTX, QNTM, COCP, UPC, NEUP, NCEL, QNRX, AYTU.

Valuation

Market cap: —
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-12.56
Shares outstanding: —

Price and trading

Previous close: 5.12
Open: 5.21
Day range: 4.93 – 5.21
52-week range: 1.92 – 150.78
52-week change: -97.05%
50-day moving average: 4.65
200-day moving average: 6.43
Beta: —
Volume: 23.66K
Average volume: 94.85K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Eps: -12.56
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 150.78
Week52 Low: 1.92
Avg Volume: 94,848.00
Ma50: 4.65
Ma200: 6.43
Pct From52w High: -96.70%
Pct From52w Low: 158.85%